Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study

Fig. 1

Area under the receiver-operating curve (AUC) analysis for exploring a threshold score for predicting sorafenib response. The risk score was calculated by using six covariates from the multivariable binary logistic regression analysis (Table 3). When the score was 6 or higher, the sorafenib response was expected to be progressive disease with maximal sensitivity and specificity

Back to article page